Eur Rev Med Pharmacol Sci 2020; 24 (1): 29-35

DOI: 10.26355/eurrev_202001_19892

MiRNA-188-5p alleviates the progression of osteosarcoma via target degrading CCNT2

F. Wang, Q.-H. Zhao, J.-Z. Liu, D.-L. Kong

Department of Orthopedics, China-Japan Union Hospital Jilin University, Changchun, China. kingdragonflight@hotmail.com


OBJECTIVE: The aim of this study was to investigate the biological role of microRNA-188-5p (miRNA-188-5p) in mediating the progression of osteosarcoma by degrading CCNT2.

PATIENTS AND METHODS: The relative expression levels of miRNA-188-5p and CCNT2 in osteosarcoma tissues and para-cancerous normal tissues were determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Meanwhile, their expression levels in osteosarcoma cell lines were examined. The regulatory effects of miRNA-188-5p on the proliferative ability and cell cycle progression of osteosarcoma cells were evaluated by Cell Counting Kit-8 (CCK-8) and flow cytometry, respectively. Dual-Luciferase reporter gene assay was applied to verify the binding relationship between miRNA-188-5p and CCNT2. Furthermore, rescue experiments were conducted to clarify the role of miRNA-188-5p/CCNT2 in mediating the progression of osteosarcoma.

RESULTS: MiRNA-188-5p was lowly expressed in osteosarcoma tissues when compared with paracancerous normal tissues. Overexpression of miRNA-188-5p significantly suppressed the proliferative ability and arrested cell cycle progression of osteosarcoma cells. However, knockdown of miRNA-188-5p obtained the opposite trends. The Dual-Luciferase reporter gene assay verified the binding relationship between miRNA-188-5p and CCNT2. The expression level of CCNT2 in HOS and MG-63 cells was markedly downregulated after transfection of miRNA-188-5p mimics. In addition, overexpression of CCNT2 could partially reverse the inhibitory effect of miRNA-188-5p on the proliferative ability and cell cycle progression of osteosarcoma cells.

CONCLUSIONS: MiRNA-188-5p is downregulated in osteosarcoma. Furthermore, it suppresses the proliferative ability and cell cycle progression of osteosarcoma cells via target degrading CCNT2.

Free PDF Download

To cite this article

F. Wang, Q.-H. Zhao, J.-Z. Liu, D.-L. Kong
MiRNA-188-5p alleviates the progression of osteosarcoma via target degrading CCNT2

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 1
Pages: 29-35
DOI: 10.26355/eurrev_202001_19892